⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17935942 | 0.78 | — | — | |
| SCHEMBL17994081 | 0.78 | — | — | |
| SCHEMBL16377750 | 0.78 | — | — | |
| SCHEMBL9551103 | 0.78 | — | — | |
| SCHEMBL17994079 | 0.78 | — | — | |
| SCHEMBL9551080 | 0.75 | — | — | |
| SCHEMBL15184362 | 0.75 | — | — | |
| SCHEMBL11662663 | 0.75 | — | — | |
| SCHEMBL14380361 | 0.75 | — | — | |
| SCHEMBL9551105 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117964584-A | Synthesis method of (R) -4-propyl-dihydrofuran-2-one | 江苏同禾药业有限公司 | 2024-05-03 | — | — | CN | claimed |
| CN-117964584-A | Synthesis method of (R) -4-propyl-dihydrofuran-2-one | 江苏同禾药业有限公司 | 2024-05-03 | — | — | CN | disclosed |
| WO-2020189555-A1 | POLYIMIDE | 三菱ケミカル株式会社 | 2020-09-24 | — | — | WO | disclosed |
| WO-2020189557-A1 | POLYIMIDE FILM | 三菱ケミカル株式会社 | 2020-09-24 | — | — | WO | disclosed |
| WO-2020189556-A1 | POLYIMIDE FILM | 三菱ケミカル株式会社 | 2020-09-24 | — | — | WO | disclosed |
| US-20190112630-A1 | PROCESSES USING AMINO ACID DEHYDROGENASES AND KETOREDUCTASE-BASED COFACTOR REGENERATING SYSTEM | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2019-04-18 | — | — | US | disclosed |
| WO-2017198775-A1 | STEREOSELECTIVE SYNTHESIS OF PHOSPHOROTHIOATE OLIGORIBONUCLEOTIDES | ETH ZURICH (CH) | 2017-11-23 | — | — | WO | disclosed |
| WO-2017132015-A1 | MOLECULES HAVING PESTICIDAL UTILITY, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES, RELATED THERETO | DOW AGROSCIENCES LLC (US) | 2017-08-03 | — | — | WO | disclosed |
| WO-2016204991-A1 | IBRUTINIB PRODRUGS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | NGUYEN MARK QUANG (US) | 2016-12-22 | — | — | WO | disclosed |
| CN-103833723-B | The manufacture method of cyclic sulfonic acid ester and intermediate thereof | 和光纯药工业株式会社 | 2016-08-17 | — | — | CN | disclosed |
| CN-102471305-A | Process for producing cyclic sulfonic acid ester and intermediate thereof | WAKO PURE CHEM IND LTD | 2012-05-23 | — | — | CN | disclosed |
| WO-2011156780-A2 | 8-(SULFONYLBENZYL)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS | AFRAXIS, INC. (US) | 2011-12-15 | — | — | WO | disclosed |
| WO-2011156775-A2 | 8-(2'-HETEROCYCYL)PYRIDO[2.3-D]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS | AFRAXIS, INC. (US) | 2011-12-15 | — | — | WO | disclosed |
| WO-2011156640-A2 | 8-(HETEROARYLMETHYL)PYRIDO[2,3-d]PYRIMIDIN-7(8H)-ONES FOR THE TREATMENT OF CNS DISORDERS | AFRAXIS, INC. (US) | 2011-12-15 | — | — | WO | disclosed |
| US-20100105890-A1 | METHOD FOR PRODUCING FURANOSE DERIVATIVE | API CORPORATION (JP) | 2010-04-29 | — | — | US | disclosed |
| EP-2105445-A1 | METHOD FOR PRODUCTION OF FURANOSE DERIVATIVE | API Corporation (JP) | 2009-09-30 | — | — | EP | disclosed |
| WO-2007146087-A2 | SUBSTITUTED PYRAZOLO [1,5-α] PYRIDINE COMPOUNDS AND THEIR METHODS OF USE | AVIGEN, INC. (US) | 2007-12-21 | — | — | WO | disclosed |
| WO-2007134434-A1 | PHENANTHRENE DERIVATIVES AS MPGES-1 INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2007-11-29 | — | — | WO | disclosed |
| EP-1135374-B9 | BENZIMIDAZOLE COMPOUNDS THAT ARE VITRONECTIN RECEPTOR ANTAGONISTS | SCHERING CORP (US) | 2007-02-21 | — | — | EP | disclosed |
| US-4105691-A | OXYCHLOROFLUORINATION, DEACON CATALYST | ALLIED CHEMICAL CORPORATION (US) | 1978-08-08 | — | — | US | disclosed |